Clinical Trials Browser

Phase 2 × Completed × olokizumab × Clear all

NCT01242488 2024-07-17

Efficacy and Safety of CDP6038 in Patients With Rheumatoid Arthritis With an Unsuccessful Response to Anti-Tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2 Completed

Arthritis, Rheumatoid

NCT01463059 2013-03-25

Efficacy and Safety of Olokizumab With Rheumatoid Arthritis With Previously Failed to Anti-tumor Necrosis Factor (Anti-TNF) Therapy

Phase 2 Completed

Arthritis, Rheumatoid